Sanaria and UMBI Win SBIR Grant for Malaria Research
Sanaria and the University of Maryland Biotechnology Institute have received a multi-year small business innovation research grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
The small business innovation research (SBIR) grant will support research and development efforts to genetically engineer mosquitoes that can enhance Sanaria’s whole-parasite malaria vaccine production process.
David O’Brochta, director of the Insect Transformation Facility at University of Maryland Biotechnology (UMBI), said: “The partnership between Sanaria and UMBI supported by this SBIR grant is an ideal example of public-private partnership in the development of groundbreaking technology.
“It presents an extraordinary opportunity to exploit the capabilities of our Insect Transformation Facility in pursuit of a goal of enormous biomedical importance.”